相关实验视频

Updated: Jul 16, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

对非小细胞肺癌的现代疗法

Andrzej Jachowski¹, Mikołaj Marcinkowski¹, Jakub Szydłowski¹

¹Department of Biochemistry and Molecular Biology, Poznań University of Medical Sciences, Święcickiego 6 Street, 60-781, Poznań, Poland.

Journal of applied genetics

|September 12, 2023

概括

现代肺癌治疗方法,包括免疫疗法和向疗法,改善了患者的治疗结果. 像CRISPR和纳米粒子这样的新兴方法为高级非小细胞肺癌 (NSCLC) 患者提供了新的希望,提高了生存率.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
纳米技术纳米技术

背景情况:

肺癌 (LC),特别是非小细胞肺癌 (NSCLC),在全球死亡率很高.
传统的治疗方法,如手术,化疗和放射治疗正在向个性化医疗发展.
个性化疗法旨在提高治疗效率并减少不良反应 (AE).

研究的目的:

审查已建立和新兴的NSCLC治疗方法.
突出诊断工具的进步,使个性化方法成为可能.
讨论现代疗法对患者生存指标的影响.

主要方法:

关于NSCLC治疗方式的当前文献的综述.
讨论已建立的疗法:免疫疗法和向疗法.
实验分子方法的探索:CRISPR和纳米粒子.

主要成果:

现代疗法,包括免疫疗法和向疗法,提高治疗疗效,减少AE.
像CRISPR和纳米粒子这样的新兴方法显示出有希望的结果和更快的恢复.
诊断技术的进步 (成像,基因分析) 促进了个性化治疗的实施.

结论:

个性化疗法和新兴的分子方法为NSCLC提供了多功能治疗选择.
这些进展改善了晚期NSCLC的整体存活率 (OS) 和无进展存活率 (PFS).
现代方法使得即使在疾病的晚期阶段,患者的生存率也更高.

关键词:

克里斯普尔是什么意思?克里斯普尔是什么意思?免疫治疗是一种免疫疗法.肺癌是一种肺癌.在NSCLCLC中,我们可以看到NSCLCLC.纳米颗粒纳米颗粒有针对性的治疗.

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...